DENDREON TARGETING CANCER, TRANSFORMING LIVES Trademark

Trademark Overview

On Friday, October 14, 2005, a trademark application was filed for DENDREON TARGETING CANCER, TRANSFORMING LIVES with the United States Patent and Trademark Office. The USPTO has given the DENDREON TARGETING CANCER, TRANSFORMING LIVES trademark a serial number of 78733522. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, July 17, 2020. This trademark is owned by Dendreon Corporation. The DENDREON TARGETING CANCER, TRANSFORMING LIVES trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Research and development of pharmaceutical products
dendreon targeting cancer, transforming lives

General Information

Serial Number78733522
Word MarkDENDREON TARGETING CANCER, TRANSFORMING LIVES
Filing DateFriday, October 14, 2005
Status710 - CANCELLED - SECTION 8
Status DateFriday, July 17, 2020
Registration Number3726707
Registration DateTuesday, December 15, 2009
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, March 14, 2006

Trademark Statements

Indication of Colors claimedColor is not claimed as a feature of the mark.
Disclaimer with Predetermined Text"CANCER"
Goods and ServicesResearch and development of pharmaceutical products

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, July 17, 2020
Primary Code042
First Use Anywhere DateFriday, April 30, 2004
First Use In Commerce DateFriday, April 30, 2004

Trademark Owner History

Party NameDENDREON PHARMACEUTICALS LLC
Party Type32 - New Owner After Registration
Legal Entity Type16 - Limited Liability Company
AddressBridgewater, NJ 08807
Party NameDENDREON PHARMACEUTICALS, INC.
Party Type31 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressBRIDGEWATER, NJ 08807
Party NameDendreon Corporation
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSeattle, WA 98121
Party NameDendreon Corporation
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSeattle, WA 98121
Party NameDendreon Corporation
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSeattle, WA 98121

Trademark Events

Event DateEvent Description
Friday, July 17, 2020CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9
Saturday, December 15, 2018COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Friday, April 21, 2017APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, April 21, 2017TEAS CHANGE OF OWNER ADDRESS RECEIVED
Saturday, April 22, 2017APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Saturday, April 22, 2017TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, April 19, 2017AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Saturday, March 19, 2016NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Saturday, March 19, 2016REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Saturday, March 19, 2016CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Tuesday, January 19, 2016TEAS SECTION 8 & 15 RECEIVED
Wednesday, July 29, 2015ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Wednesday, July 15, 2015AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Wednesday, May 20, 2015ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, May 20, 2015TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, November 5, 2013TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, December 15, 2009REGISTERED-PRINCIPAL REGISTER
Friday, November 6, 2009LAW OFFICE REGISTRATION REVIEW COMPLETED
Thursday, November 5, 2009ASSIGNED TO LIE
Thursday, October 22, 2009ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Monday, October 5, 2009STATEMENT OF USE PROCESSING COMPLETE
Thursday, October 1, 2009USE AMENDMENT FILED
Thursday, October 1, 2009TEAS STATEMENT OF USE RECEIVED
Friday, October 2, 2009EXTENSION 3 GRANTED
Monday, September 28, 2009EXTENSION 3 FILED
Monday, September 28, 2009TEAS EXTENSION RECEIVED
Thursday, July 23, 2009APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, July 21, 2009PAPER RECEIVED
Friday, May 29, 2009EXTENSION 2 GRANTED
Friday, May 22, 2009EXTENSION 2 FILED
Friday, May 22, 2009TEAS EXTENSION RECEIVED
Friday, December 12, 2008EXTENSION 1 GRANTED
Wednesday, December 3, 2008EXTENSION 1 FILED
Friday, December 12, 2008CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, December 3, 2008TEAS EXTENSION RECEIVED
Tuesday, June 3, 2008NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, April 22, 2008TTAB RELEASE CASE TO TRADEMARKS
Tuesday, April 22, 2008OPPOSITION TERMINATED NO. 999999
Tuesday, April 22, 2008OPPOSITION DISMISSED NO. 999999
Thursday, May 25, 2006OPPOSITION INSTITUTED NO. 999999
Monday, April 3, 2006EXTENSION OF TIME TO OPPOSE RECEIVED
Tuesday, March 14, 2006PUBLISHED FOR OPPOSITION
Wednesday, February 22, 2006NOTICE OF PUBLICATION
Thursday, January 26, 2006LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, January 20, 2006ASSIGNED TO LIE
Friday, January 13, 2006APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, January 13, 2006EXAMINER'S AMENDMENT ENTERED
Friday, January 13, 2006EXAMINERS AMENDMENT E-MAILED
Friday, January 13, 2006EXAMINERS AMENDMENT -WRITTEN
Wednesday, January 4, 2006ASSIGNED TO EXAMINER
Thursday, October 20, 2005NEW APPLICATION ENTERED IN TRAM

Related Keywords

lives transforming cancer targeting dendreon products pharmaceutical development research